National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Iluvien® is indicated for the treatment of vision impairment associated with chronic diabetic macular oedema (DMO) considered insufficiently responsive to available therapies.

Rapid Review

Commenced Completed Outcome
15/02/2016 01/03/2016 Full Pharmacoeconomic Evaluation Not Recommended